UK based pharma major, AstraZeneca Plc (LON:AZN), which is developing COVID-19 vaccine with the University of Oxford stated that it had paused late-stage trial of the COVID-19 vaccine candidate.
The trial was put on hold after a volunteer developed some unexplained illness.
AstraZeneca/Oxford COVID-19 vaccine AZD1222 is under late-stages of clinical trials.
The Company stated it voluntarily paused vaccination for review of safety information by an independent committee.
The interruption of the clinical trial has impacted other vaccine trials of AstraZeneca and ongoing trials by other vaccine developers.